Germany Approves Exilby Cannabis; FDA Grants Breakthrough Therapy
Exilby, a whole plant botanical cannabis treatment, has received marketing authorization in Germany, marking a significant milestone in the acceptance of cannabis-based therapies in Europe. Concurrently, the United States Food and Drug Administration (FDA) has granted Exilby a Breakthrough Therapy Designation, a signal of the drug’s potential to treat serious conditions more effectively than existing…

